Showing results (281-290 of 941) with videos related to
Sort By:
Pageof 95
Neurology and Therapy|November 30, 2016
Prescription Patterns of Medications for Alzheimer's Disease in Japan from 2010 to 2015: A Descriptive Pharmacy Claims Database StudyKimiko Kadohara, Izumi Sato, Yuko Doi, et al.Neurology and Therapy|April 21, 2023
Effect of mTOR Inhibitors in Epilepsy Treatment in Children with Tuberous Sclerosis Complex Under 2 Years of AgeDominika Śmiałek, Katarzyna Kotulska, Aleksandra Duda, et al.Neurology and Therapy|April 28, 2023
Evidence-Based Pharmacotherapy of Anxiety Symptoms in Patients with Major Depressive Disorder: Focus on AgomelatineDan J SteinNeurology and Therapy|May 17, 2023
Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort StudyJ Bradley Layton, Mary E Ritchey, Zhongwen Huang, et al.Neurology and Therapy|April 22, 2021
STO: Stroke Ontology for Accelerating Translational Stroke ResearchMahdi Habibi-Koolaee, Leila Shahmoradi, Sharareh R Niakan Kalhori, et al.Neurology and Therapy|April 20, 2021
Comprehensive Approach to Management of Multiple Sclerosis: Addressing Invisible Symptoms-A Narrative ReviewLynsey Lakin, Bryan E Davis, Cherie C Binns, et al.Neurology and Therapy|November 22, 2019
Knowledge Is Power, but Is Ignorance Bliss? Optimising Conversations About Disease Progression in Multiple SclerosisPatrick Vermersch, Jane Shanahan, Dawn Langdon, et al.Neurology and Therapy|November 6, 2019
Correction to: Abstracts from the 5th International Porto Congress of Multiple SclerosisMaria José SáNeurology and Therapy|November 8, 2019
Fingolimod Immune Effects Beyond Its Sequestration AbilityFrancesco Sica, Diego Centonze, Fabio ButtariNeurology and Therapy|December 14, 2019
Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID TechnologyLih-Fen Lue, Yu-Min Kuo, Marwan SabbaghPageof 95